Article
Restoration of daptomycin sensitivity with adjunctive cefazolin is associated with C-terminal MprF mutations in MRSA bacteremia isolates.
Antimicrobial agents and chemotherapy - 3 Jun 2026
Davis Kathleen P, Poonawala Husain, Murphy Connor, Thorpe Cheleste, Rosato Adriana, Aldridge Bree B
Abstract excerpt
Daptomycin (DAP) or vancomycin (VAN) resistance can result in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia treatment failure. Clinical trials have not yielded a clear approach to MRSA combination therapy. Furthermore, there is not a protocol approved by the Clinical Laboratory Standards Institute (CLSI) for testing most possible antibiotic combinations, and methodology used in basic research...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
